ALB vs RPM vs SOLS
161 measures in 16 categories, one definition each, computed from filings and market data.
ALB71.6
Albemarle Corporation
Basic Materials · Chemicals - Specialty
$95.48 −2.73%$11.3B mkt cap
Score DNA
RPM62.2
RPM International Inc.
Basic Materials · Chemicals - Specialty
$99.73 −0.36%$12.7B mkt cap
Score DNA
SOLS45.1
Solstice Advanced Materials Inc.
Basic Materials · Chemicals - Specialty
$59.25 −1.12%$9.4B mkt cap
Score DNA
Price, rebased to 100 three years ago
ALB RPM SOLS · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 3 | 1 | 0 |
| Last Congress purchase | 2026-09-25 | 2026-10-09 | — |
| 13F net change in holders | −42 | +37 | +34 |
| ETFs adding shares, 30d | 710 | 402 | 286 |
| ETFs trimming, 30d | 560 | 284 | 249 |
| Net ETF funds, 30d | +150 | +118 | +37 |
Valuation
16 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| P/E (TTM) | 50.3x
92nd
|
18.4x
24th
|
38.4x
80th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | 1.68
21st
|
— |
| Price / sales | 1.9x
56th
|
1.6x
51st
|
3.0x
78th
|
| Price / book | 1.1x
8th
|
3.7x
68th
|
5.9x
90th
|
| Price / tangible book | 2.1x
21st
|
13.5x
72nd
|
19.5x
86th
|
| Price / free cash flow | 8.4x
8th
|
18.0x
50th
|
30.5x
67th
|
| Price / operating cash flow | 6.3x
15th
|
13.7x
60th
|
15.0x
65th
|
| Enterprise value | $11.6B
74th
|
$15.1B
81st
|
$11.1B
71st
|
| EV / sales | 2.0x
54th
|
1.9x
51st
|
3.5x
78th
|
| EV / EBITDA | 9.9x
23rd
|
11.9x
43rd
|
16.6x
57th
|
| EV / EBIT | 21.7x
40th
|
14.3x
20th
|
22.3x
43rd
|
| EV / free cash flow | 8.7x
0th
|
21.5x
39th
|
35.8x
69th
|
| Earnings yield | 2.0%
45th
|
5.4%
86th
|
2.6%
52nd
|
| FCF yield | 11.9%
93rd
|
5.5%
57th
|
3.3%
43rd
|
| Operating cash flow yield | 16.0%
86th
|
7.3%
43rd
|
6.7%
38th
|
| Graham number (per share) | $52.85
52nd
|
$57.76
64th
|
$18.56
12th
|
Profitability (TTM)
12 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| Gross margin | 23.9%
40th
|
41.2%
86th
|
30.6%
52nd
|
| EBITDA margin | 19.9%
80th
|
16.0%
56th
|
21.3%
85th
|
| Operating margin | 11.9%
60th
|
12.5%
65th
|
16.7%
82nd
|
| EBIT margin | 9.0%
51st
|
13.3%
68th
|
15.9%
80th
|
| Net margin | 3.8%
44th
|
8.7%
76th
|
7.8%
73rd
|
| NOPAT margin | 8.0%
59th
|
9.5%
66th
|
12.3%
76th
|
| FCF margin | 22.7%
98th
|
8.9%
59th
|
9.9%
66th
|
| Operating cash flow margin | 30.5%
95th
|
11.6%
49th
|
20.1%
80th
|
| R&D / revenue | 0.6%
51st
|
0.0%
0th
|
2.6%
80th
|
| SG&A / revenue | 9.2%
32nd
|
28.6%
90th
|
10.9%
39th
|
| Stock comp / revenue | 0.6%
63rd
|
0.5%
54th
|
0.4%
41st
|
| Effective tax rate | 33.2%
88th
|
24.1%
71st
|
26.4%
83rd
|
Returns on capital
11 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| ROE (on average equity) | 2.2%
41st
|
21.1%
85th
|
15.4%
71st
|
| ROA | 1.4%
45th
|
8.5%
86th
|
4.1%
62nd
|
| ROIC | 4.4%
45th
|
12.8%
81st
|
11.8%
74th
|
| ROCE | 3.8%
40th
|
16.7%
86th
|
11.9%
71st
|
| Return on tangible assets | 3.2%
40th
|
13.1%
86th
|
8.4%
67th
|
| Cash ROIC (OCF / invested capital) | 16.9%
74th
|
15.7%
67th
|
19.3%
83rd
|
| Gross profitability (GP / assets) | 8.9%
14th
|
39.8%
95th
|
16.0%
45th
|
| ROIC, 3-yr average | -1.2%
23rd
|
10.4%
82nd
|
— |
| ROIC, 5-yr average | 7.0%
54th
|
12.0%
79th
|
— |
| ROE, 5-yr average | 6.6%
39th
|
22.9%
87th
|
— |
| Incremental ROIC | -64.3%
30th
|
150.2%
95th
|
— |
Growth
17 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| Revenue growth (TTM YoY) | 18.3%
85th
|
6.0%
59th
|
— |
| Revenue growth (QoQ) | 22.0%
81st
|
-0.7%
2nd
|
15.8%
62nd
|
| Revenue CAGR, 3 yr | -15.1%
0th
|
2.8%
72nd
|
— |
| Revenue CAGR, 5 yr | 12.8%
92nd
|
5.3%
63rd
|
— |
| Gross profit CAGR, 3 yr | -28.6%
8th
|
5.0%
64th
|
— |
| Operating income CAGR, 3 yr | -38.1%
0th
|
6.6%
54th
|
— |
| Net income growth (TTM YoY) | — | 0.2%
39th
|
— |
| Net income CAGR, 3 yr | -61.5%
0th
|
10.6%
73rd
|
— |
| EPS growth (TTM YoY) | — | 0.8%
39th
|
— |
| EPS CAGR, 3 yr | -63.3%
0th
|
11.0%
73rd
|
— |
| EPS CAGR, 5 yr | -22.8%
0th
|
8.8%
61st
|
— |
| FCF growth (TTM YoY) | — | 36.7%
78th
|
— |
| FCF CAGR, 3 yr | 11.7%
61st
|
2.0%
36th
|
— |
| Operating cash flow CAGR, 3 yr | -12.0%
23rd
|
0.4%
49th
|
— |
| Book value CAGR, 3 yr | -3.3%
26th
|
15.6%
87th
|
— |
| Dividend CAGR, 3 yr | -4.7%
6th
|
2.2%
53rd
|
— |
| Sustainable growth rate | -1.3%
0th
|
12.7%
60th
|
13.9%
72nd
|
Margin history & stability
7 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| Gross margin, 3-yr average | 7.8%
5th
|
41.3%
90th
|
— |
| Operating margin, 3-yr average | -10.4%
8th
|
12.4%
65th
|
— |
| Net margin, 3-yr average | -7.2%
18th
|
8.8%
75th
|
— |
| FCF margin, 3-yr average | 0.7%
20th
|
8.9%
68th
|
— |
| Revenue stability (0-1) | 0.04
5th
|
0.91
83rd
|
— |
| Earnings stability (0-1) | 0.10
22nd
|
0.92
95th
|
— |
| Margin stability (0-1) | 0.00
0th
|
0.96
95th
|
— |
Liquidity (latest quarter)
7 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| Cash & short-term investments | $1.6B
88th
|
$312.8M
62nd
|
$750.0M
81st
|
| Net cash (− = net debt) | −$354.1M
81st
|
−$2.4B
26th
|
−$1.7B
36th
|
| Working capital | $2.1B
86th
|
$1.5B
83rd
|
$808.0M
67th
|
| Current ratio | 2.09
60th
|
1.76
45th
|
1.46
21st
|
| Quick ratio | 1.35
57th
|
1.16
50th
|
1.08
38th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.86
86th
|
0.16
29th
|
0.43
67th
|
| Defensive interval (days) | 1,217 days
93rd
|
293 days
10th
|
1,497 days
95th
|
Leverage & solvency (latest quarter)
13 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| Total debt | $2.0B
60th
|
$2.7B
71st
|
$2.4B
69th
|
| Debt / equity | 0.19
10th
|
0.79
50th
|
1.52
85th
|
| Net debt / equity | 0.03
10th
|
0.70
60th
|
1.05
78th
|
| Debt / assets | 12.5%
7th
|
33.3%
52nd
|
40.7%
69th
|
| Debt / capital | 16.2%
10th
|
44.1%
50th
|
60.3%
85th
|
| Debt / EBITDA | 1.69
17th
|
2.16
29th
|
3.62
43rd
|
| Net debt / EBITDA | 0.30
6th
|
1.91
29th
|
2.49
43rd
|
| Interest coverage (EBIT / interest) | 3.1x
48th
|
9.8x
80th
|
6.6x
65th
|
| Cash interest coverage | 10.4x
80th
|
8.6x
70th
|
8.4x
62nd
|
| Debt payback (years of OCF) | 1.1 yrs
8th
|
3.0 yrs
28th
|
3.8 yrs
40th
|
| Liabilities / assets | 34.0%
10th
|
57.7%
52nd
|
73.2%
81st
|
| IS credit model rating | A | A | BBB |
| Implied credit spread (bps) | 150
21st
|
150
21st
|
275
40th
|
Efficiency
11 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| Asset turnover | 0.36
10th
|
0.98
81st
|
0.53
24th
|
| Fixed asset turnover | 0.70
7th
|
4.10
88th
|
1.47
17th
|
| Inventory turnover | 3.0
12th
|
4.2
39th
|
3.3
20th
|
| Receivables turnover | 8.6
79th
|
5.3
31st
|
4.7
10th
|
| Days sales outstanding | 42 days
21st
|
69 days
69th
|
78 days
90th
|
| Days inventory outstanding | 123 days
88th
|
86 days
61st
|
111 days
80th
|
| Days payables outstanding | 62 days
64th
|
64 days
69th
|
158 days
100th
|
| Cash conversion cycle (days) | 103 days
71st
|
90 days
52nd
|
32 days
7th
|
| Capex / revenue | 7.8%
78th
|
2.8%
15th
|
10.2%
88th
|
| Capex / depreciation | 0.71
32nd
|
1.02
56th
|
1.87
93rd
|
| Operating expense ratio | 7.9%
10th
|
25.5%
68th
|
12.9%
37th
|
Cash flow & earnings quality
7 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| Operating cash flow / net income | 8.03
100th
|
1.34
24th
|
2.56
80th
|
| FCF / net income | 5.99
96th
|
1.02
40th
|
1.26
68th
|
| FCF / operating cash flow | 74.6%
72nd
|
76.3%
74th
|
49.3%
31st
|
| Capex / operating cash flow | 25.4%
28th
|
23.7%
26th
|
50.7%
69th
|
| Accruals ratio | -9.5%
29th
|
-2.9%
81st
|
-6.5%
52nd
|
| Sloan accruals ratio | -6.9%
26th
|
-6.8%
29th
|
4.0%
90th
|
| Earnings quality score (0-1) | 0.75
4th
|
1.00
40th
|
0.75
4th
|
Scores & forensic checks
15 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| IS score | 72
98th
|
62
81st
|
45
50th
|
| IS profitability | 49
74th
|
57
81st
|
46
69th
|
| IS growth | 70
95th
|
45
37th
|
— |
| IS value | 47
50th
|
54
69th
|
29
10th
|
| IS momentum | 96
98th
|
74
61st
|
— |
| IS risk (safety) | 80
62nd
|
90
71st
|
65
50th
|
| IS quality | 79
93rd
|
74
81st
|
61
52nd
|
| IS balance sheet | 73
86th
|
63
74th
|
53
57th
|
| IS earnings quality | 69
57th
|
75
83rd
|
62
45th
|
| IS cash flow | 71
93rd
|
65
86th
|
51
55th
|
| Piotroski F-score (0-9) | 7
71st
|
6
52nd
|
4
12th
|
| Altman Z-score | 3.1
64th
|
3.9
76th
|
3.0
60th
|
| Beneish M-score | −3.25
5th
|
−2.56
66th
|
— |
| Ohlson O-score | −10.14
0th
|
−7.90
31st
|
−7.09
55th
|
| IS credit score | 74
79th
|
70
69th
|
58
52nd
|
Size (TTM)
8 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| Market cap | $11.3B
79th
|
$12.7B
81st
|
$9.4B
76th
|
| Revenue | $5.9B
74th
|
$8.0B
79th
|
$3.1B
55th
|
| EBITDA | $1.2B
76th
|
$1.3B
79th
|
$666.0M
67th
|
| Net income | $224.2M
74th
|
$690.1M
88th
|
$245.0M
76th
|
| Free cash flow | $1.3B
83rd
|
$705.6M
81st
|
$309.0M
67th
|
| Total assets | $15.9B
79th
|
$8.2B
74th
|
$5.9B
64th
|
| Shareholders' equity | $10.3B
90th
|
$3.5B
74th
|
$1.6B
55th
|
| Employees | 7,800
71st
|
17,546
83rd
|
4,100
55th
|
Price performance
9 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| 1 day | −2.7% | −0.4% | −1.1% |
| 1 week | −5.7% | +2.0% | −3.4% |
| 1 month | −17.0% | +0.6% | +0.8% |
| 3 months | −19.2% | −1.9% | +4.9% |
| 6 months | −51.7% | −9.2% | −27.0% |
| Year to date | −33.6% | −3.4% | +20.4% |
| 1 year | −2.4% | −11.8% | — |
| 3 years, cumulative | −39.7% | +4.2% | — |
| 5 years, cumulative | −53.2% | +36.4% | — |
Technicals
4 measures| Measure | ALB | RPM | SOLS |
|---|---|---|---|
| RSI 14 | 26.4 | 49.2 | 49.1 |
| From 52-week high | −56.8% | −18.1% | — |
| From 52-week low | +8.8% | +7.3% | — |
| Beta | 1.36 | 1.04 | 0.49 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17